Loading organizations...
§ Private Profile · Cleveland, OH, USA
Medical device company developing neurostimulation pain therapies.
SPR Therapeutics has raised $155.3M across 7 funding rounds.
SPR Therapeutics has raised $155.3M in total across 7 funding rounds.
SPR Therapeutics has raised $155.3M across 7 funding rounds. Most recently, it raised $85.0M Debt / Series D in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2024 | $85M Debt Financing | Scott Halsted | Mutual Capital Partners, SLR Capital Partners | Announced |
| Oct 18, 2021 | $37M Series D | Scott Halsted | Mutual Capital Partners | Announced |
| Sep 12, 2017 | $25M Series C | Frontcourt Group | — | Announced |
| Jan 8, 2013 | $5M Series A | — | NDI Healthcare Fund, Public Square Partners | Announced |
| May 24, 2012 | $900K Debt Financing | State OF Ohio | — | Announced |
| Jan 24, 2012 | $2.2M Series A | NDI Healthcare Fund | — | Announced |
| Apr 27, 2011 | $250K Venture Round | JumpStart Ventures | — | Announced |
SPR Therapeutics has raised $155.3M in total across 7 funding rounds.
SPR Therapeutics's investors include Scott Halsted, Mutual Capital Partners, SLR Capital Partners, Frontcourt Group, NDI Healthcare Fund, Public Square Partners, State of Ohio, JumpStart Ventures.